Rekhati S. Abhayawardana

Publications

209

Citations

H-Index

2016

Active since

Affiliations

The University of Western Australia(Current)

University of Birmingham

University of Nottingham

Harry Perkins Institute of Medical Research

Rekhati S. Abhayawardana is an author at The University of Western Australia specializing in molecular physiology, cell signaling, and molecular pharmacology.

Top concepts

MedicinePhysiologyCell SignalingSignal TransductionMolecular PhysiologyMolecular PharmacologyHealthUrologyImmunologyCell Biology

Publications per year

2016–2024

Publications

Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis

R. J. Pickering, Christos Tikellis, Carlos J. Rosado et al. · Journal of Clinical Investigation · 2018 · 82 citations · Full text

Immunology, Renal Inflammation, Inflammation +23

Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking

Anatoly Tiulpakov, Carl W. White, Rekhati S. Abhayawardana et al. · Molecular Endocrinology · 2016 · 54 citations · Full text

Cellular Physiology, Inappropriate Antidiuresis, Vasopressin Receptor 2 +24

Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties

Harriet A. Watkins, Madhuri Chakravarthy, Rekhati S. Abhayawardana et al. · Journal of Biological Chemistry · 2016 · 37 citations · Full text

CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans

Carl W. White, Simon Platt, Laura E. Kilpatrick et al. · Science Signaling · 2024 · 19 citations · Full text

Investigation of Receptor Heteromers Using NanoBRET Ligand Binding

Elizabeth K. M. Johnstone, Heng B. See, Rekhati S. Abhayawardana et al. · International Journal of Molecular Sciences · 2021 · 17 citations · Full text

Rows per page

1–5 of 5